Improvement of the new phosphite method for the synthesis of oligodeoxyribonucleotides using the deoxyribonucleoside 3'-bis(1,1,1,3,3,3-hexafluoro-2-propyl) phosphite unit has been carried out via the hydrolysis and capping steps, without any side reaction products. The new phosphite unit and capping agent, bis(1,1,1,3,3,3-hexafluoro-2-propyl)-2-propyl phosphite, is readily activated by N-methylimdazole under very mild condition on a solid support. This operation involves a one pot reaction, which is an advantage over both the phosphite and H-phosphonate approaches. The mechanism of internucleotidic bond formation of the new phosphite method is also discussed.
INTRODUCTION
Recently, the developments of phosphite [1] , phosphoramidite [2] , and H-phosphonate [3] approaches have enabled the rapid chemical synthesis of oligo-and polydeoxyribonucleotides on solid supports. The phosphoramidite approach has been accessible and more successful in application to molecular biology. However, the phosphoramidite approach requires a phosphate protecting group and capping and oxidation reaction (an oxidation reaction is carried out at the end of each coupling reaction) during the course of synthesis compared with the H-phosphonate approach. On the other hand, the H-phosphonate approach also has some disadvantages: instability of the coupling agent (pivaloyl chloride) [4] [5] [6] and necessity for a large excess of the phosphitylating agent to prepare the H-phosphonate units [5, 6] .
In a current study, we have reported [7] a simple method for the synthesis of deoxyribonucleoside 3'-H-phosphonates using the transesterification of a new agent, bis(l,l,l,3,3,3-hexafluoro-2-propyl) phosphonate. This phosphonylating agent was easily activated by pyridine to give the reactive N-phosphonylpyridine intermediates.
Based upon the above facts, we considered whether deoxyribonucleoside 3'-bis(l, 1,1,3,3,3-hexafluoro-2-propyl) phosphites (3) could be used as new monomer building blocks that had high reactivity as a trivalent phosphorus compound, like trialkyl phosphites [8] . Therefore, we have studied the synthesis of oligodeoxyribonucleotides by use of the phosphite units (3) on solid support [9] . However, we now found that the oligodeoxyribonucleotides prepared by our phosphite method is contaminated by small amoounts of the side product, long size oligomer than desired oligomer. In an attempt to improve our original approach, our syntheses were carried out to evaluate the relative effectiveness of the two different synthetic cycles and the effect of capping during oligonucleotide synthesis. Further, the mechanism of internucleotidic bond formation of the new phosphite method is also discussed.
GENERAL MATERIALS AND METHODS
'H-NMR spectra were recorded on a JEOL JNMPS 100 spectrometer with TMS as an internal standard.
31
P-NMR spectra were recorded in CH 3 CN or CDC1 3 on a Bruker AM-400 spectrometer using 85% H 3 PO 4 as an internal standard. Ultraviolet spectra were recorded on a Shimazu UV-160 spectrometer. Thin layer chromatography (TLC) was carried out on Merck Kieselgel 6OF254 plates which were developed in system A (CH 2 Cl 2 -Me0H, 9:1, v/v), system B (CH 2 Cl 2 -Me0H, 95:5, v/v). Reverse phase TLC was carried out on Merck silanized silica gel;[RP-8F 60F 254 ]plates with a mixture of acetone and 0.02 M triethylammonium acetate (TEAA) (6:4, v/v) as the eluting agent. Column chromatography was carried out on silica gel (BW-300; Fuji Davison Co.Ltd.) and alkylated silica gel (C-18, Waters Associates Inc.). THF was continuously refluxed over sodium/benzophenone and distilled prior to use. CH 2 C1 2 was distilled from P 2 O 5 and stored over activated 4-A molecular sieves. CH 3 CN was distilled twice from P 2 O 5 and from CaH 2 and then stored over activated 4-A molecular sieves. Pyridine was distilled twice from /?-toluenesufonyl chloride and from CaH 2 and then stored over activated 4-A molecular sieves. N,N,-Diisopropylethylamine, DMF, and lutidine were freshly distilled from CaH 2 . Dicylcohexylcarbodiimide (DCC) and CS 2 were redistilled before use. 1,1,1,3,3,3-Hexafluoro-2-propanol was purchased from Sentral Glass Co. Ltd.. Long-chain alkylamino controlled pore glass was purchased from Electro Nucleonics Inc. Snake venom phosphodiesterase and alkaline phosphatase were purchased from Beohringer Mannhein.
The chain elongation steps were carried out in an Applied Biosystems Model 381A DNA synthesizer using CPG column containing 0.2 /imol of partially-protected dT and dA.
Electrophoretic gels were either 20% polycarylamide/7 M urea and run at 400V.
Reverse-phase HPLC was performed on a Shimazu LC-6A system using a TSKgel oligo-DNA RP for analysis and Inertsil ODS for purification with a linear gradient of CH 3 CN in 0.1 M triethylammonium acetate (pH 7.0). For anion exchange HPLC, the TSKgel DEAE-2SW, DEAE-NPR, and DEAE 5PW columns were used with a linear gradient of ammonium formate in 20% CH 3 CN.
The dT-CPG (39 /imol/g) and dA-CPG (28 /tmol/g) were prepared as described previously [10] .
Preparation of Deoxyriboucleoside 3'-Bis(l,l,l,3,3,3-2-Propyl) Phosphites(3) After co-evaporation with dry pyridine, N-acyl-5'-Odimethoxytritylnucleosides (1) (1 mmol) was dissolved in CH 2 C1 2 (10 ml) and tris-(l,l,l,3,3,3-hexafluoro-2-propyl) phosphite (2) (0.34 ml, 1.2 mmol) was added. After 5 min, the mixture solution was poured into n-hexane and the supernatant solution was taken off from the reaction mixture. The residue was co-evapolated with n-hexane to give a white foam, which could be used as the phosphite unit directly in the coupling reaction, or could be purified, if necessary, by silica gel column chromatography. 
5' -0-(Dimethoxytrityl)-3' -thymidine 3 -O-(Benzoyl)-5' -thymidine Phosphonate (4).
The phosphite unit (3a) (976 mg, 1 mmol) was treated with 3'-Obenzoylthymidine (380 mg, 1.1 mmol) in the presence of Melm (0.24 ml, 3 mmol) in CH 3 CN (1 ml). After 10 min, the mixture was quenched with 0.1 M Melm/2%H 2 O-THF and the solution was extracted with CH 2 C1 2 (5 mix2). The organic layer was dried over Na 2 SO 4 , evaporated and chromatographed on silica gel to give 4 (836 mg, 89%).
31 P-NMR (CDC1 3 , 85% H 3 PO 4 ) 8 8.63, 7.33 ppm.
Synthesis of a Capping Agent (6)
To a solution of 2-propyl phosphorodichloridite (20.1 g, 125 mmol) and triethylamine (48.8 ml, 350 mmol) in dry ether (150 ml) at -20°C, l,l,l,3,3,3-hexafluoro-2-propanol (52.8 ml, 500 mmol) in dry ether (50 ml) was added. The mixture was allowed to warm up to room temperature, and was stirred for an additional 12 h. Petroleum ether (100 ml) was then added. The products were kept overnight at 4°C and were filtered. The filtrate was concentrated, and the residue was distilled under reduce pressure. The main fraction (43.3g, 82%) was obtained as a colorless liquid: b.p. 48°C/18 mmHg; 31 P-NMR (CDC1 3 , 85% H 3 PO 4 ) 6139.9 ppm.
Synthesis of Oligodeoxyribonucleotides
The LCAA-CPG support loaded with first nucleoside (0.2 /tmol) was packed in a small ABI column which is part of an Applied Biosystems 381A DNA Synthesizer. The reaction cycle of chain elongation was were carried out by a control programmed series of reagent and solvent washes based on a program of the DNA synthesis with the following modifications: 1) coupling: 0.25 M phosphite unit (3) and 0.5 M methylimidazole in dry CH 3 CN in delivered in 4 alternating burst of 4 sec (Melm) followed by 10 sec (phosphite + Melm) with wait time 5min.
2) unblocking: 3% trichloroacetic acid in CH 
Deprotection and Isolation of Oligodeoxyribonucleotides
After oxidation, the column was washed with CH 3 CN and ether. Further the column was treated with concentrated ammonia for 1 h at room temperature. The solution was eluted from column and heated in a sealed vial at 55°C for 5-8 h, except oligonucleotides. The solution was concentrated and the residue was dissolved in water. The solution was passed through a membrane filter (EKICRODISC 13, Gelman Sciences Japan) [11] . The deprotected oligonucleotide was analyzed and purified by the anion exchange HPLC or reverse phase HPLC. The appropriate fractions were collected and lyophilized from sterile water. The purify and chain length were analyzed by anion exchange HPLC and PAEG.
Enzymatic Digestions
The oligonucleotide (0.2 A 260 units) was dissolved in 0.01 M TRIS/HC1 buffer (pH 8.8) (500 /d) and digested with snake venom phosphodiesterase (5 /ig) at 37°C for 2 h. The mixture was further incubated with alkaline phosphatase (5 /ig) at 37 °C for 1 h. Degradation products were analyzed by the reverse phase HPLC using a TSKgel oligo-DNA RP with a nonlinear gradient of CH 3 CN (5% during 60 min) in 0.1 M TEAA (pH 7.0).
RESULTS AND DISCUSSION
First, the required building blocks (3) were readily prepared by allowing the deoxyribonucleosides (1) to react with a slight excess of tris(l, 1,1,3,3,3-hexafluoro-2-propyl) phosphite 2 [6, 12] (1.2 molar equiv.) in CH 2 C1 2 for 10 min, followed by washing workup and chromatography of the products. Isolated yields and 3I P-NMR spectroscopic data are listed in the experimental section. On the other hand, the building blocks (3) used in the coupling reaction were purified by washing with dry n-hexane to yield on co-evaporation colorless foams, which were 31 P-NMR spectroscopically pure (Scheme 1).
In order to investigate the utility of these phosphite units (3) as starting materials for oligodeoxyribonucleotide synthesis, several experiments have been made. The coupling properties of the phosphite units (3a) were first studied with 3'-Obenzoylthymidine (1.1 molar equiv.) in the presence of Nmethylimidazole (Melm) at room temperature. After 10 min, the reaction was monitored by 31 P-NMR spectroscopy. The spectrum of the reaction mixture showed that the signal of the phosphite unit (3a) completely disappeared. New signals were observed at 8.68 and 7.33 ppm. The chemical shift suggested that 3a was readily converted to the corresponding H-phosphonate diester (4). The protected dithymidine (3'-5') phosphonate (4) was isolated in high yield (89%) without any side reaction products.
The rate of formation of the internucleotidic bond depended on the base agent. It was found that when N-ethylmorpholine, 4-(dimethylamino)pyridine (DMAP), and tri-n-buthylamine were used as base agents, the internucleotidic bond was not completely formed on a practical time scale (Figure 1 ). When Nmethylimidazole (Melm) or N-ethylimidazole (Etlm) was used, the internucleotidic bond was nearly formed within 2 min. The yield, however, slightly increased with Melm.
Next, we decided to investigate the activation process and the
B:a=T b=bzA c=anC d=ibuG (2) DMTrO-^O B
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Scheme 1
coupling reaction using 3I P-NMR spectroscopy (Figure 2) . The phosphite unit (3a) (1 molar equiv.) was dissolved in dry CH 3 CN and the solution was monitored by 31 P-NMR (Figure 2a) . A peak at 140.2 ppm in the low field region was assigned to the phosphite unit (3a). Moreover, when Melm (5 molar equiv.) was added to the above mixture, the corresponding intermadiate N-methylimidazolium (5) was not observed as a 31 P-NMR resonance peak. The intermediate 5 that must be present in equilibrium with 3, most be so reactive intermediate that the equilibrium lies predominantly towards 3 (Scheme 2). Finally, to the resulting solution was added 3'-Obenzoylthymidine (1.5 molar equiv.). The spectrum of the reaction mixture then showed that the double new peak was observed at high field region (8.55 and 7.61ppm) corresponded to the H-phosphonate diester (4) (Figure 2b) .
To ascertain the coupling efficiency of a new phosphite approach, we tried to effect solid phase synthesis of d-(Tp) 14 31 P-NMR spectra of the reaction mixture for the H-phosphonate internucleotidic bond formation, a) 3a was dissolved in C1 3 CD. b) 3'-O-Benzoylthymidine was added to the mixture of 3a and Melm.
(Scheme 3). The reaction was carried out on controlled pore glass (14 mg, 17.5 /imol/g) [10] with an Applied Biosystems Model 381A DNA synthesizer. Our first syntheses were carried out to evaluate the relative effectiveness of the two different synthetic cycles and the effect of the phosphite unit concentration on coupling yield. For these syntheses the synthetic cycles used are shown in Table 1 and are referred to as cycle A and B. Cycle A was not satisfactory for the synthesis of d(Tp) 14 T; oligomers longer than the desired oligomer were found using synthetic cycle A (Figure 3, lane 2) . It was necessary to add a hydrolytic step, cycle B, shown in Table 1 . In this case, the desired oligomers were obtained without any by-products (Figure 3, lane 3) .
Further, d-(Tp) 14 It has been clearly shown by Andrus et al. [4] that a capping reaction for the unreacted 5'-hydroxyl group is necessary in the chemical synthesis of oligodeoxyribonucleotides by the Hphosphonate approach on a solid support. We have found evidence by HPLC that the coupling reaction is approximately 96% efficient in converting 3'-O-benzoylthymidine to 4. 4% of the 3'-O-benzoylthymidine remains, and the 5'-hydroxyl groups are available for reaction in the next cycle. Consequently, without an effective capping reaction, oligodeoxyribonucleotides cannot be purified free from the deletion sequences (Figure 4, compare  lanes 1 and 3) .
We first tested the agent (Ac 2 O/DMAP) used for capping in the phosphoramidite approach [13] . However, the coupling reaction did not proceed smoothly and the product contained some impurities which could not be separated by HPLC. In order to overcome this problem, we have looked for a more effective capping agent for the unreacted 5'-hydroxyl group in the Hphosphonate approach. We found that bis(l,1,1,3,3,3-hexafluoro-2-propyl)-2-propyl phosphite (HFPP)(6) is effective. It can be easily prepared in 82 % yield by treatment of 2-propyl phosphorodichloridite with l,l,l,3,3,3-hexafluoro-2-propanol in the presence of triethylamine and can be readily activated by Melm under very mild conditions (Scheme 4). The capping properties of 6 were first studied with 3'-O-benzoylthymidine (1.2 molar equiv.) and 6 (1.0 molar equiv.) in the presence of Melm in CH 3 CN at room temperature. After 10 min, the reaction mixture was treated with 0.1 M Melm in THF:H 2 O (98:2, v/v) and the reaction was monitored by 31 P-NMR spectroscopy. The spectrum of the reaction mixture showed that a signal of the capping agent 6 completely disappeared; new signals were observed at 8.07 and 7.22 ppm. The chemical shift suggested that 6 was readily converted into the corresponding H-phosphonate diester (7). 
(1) 
(1) On the basis of this finding, a capping step was added to the synthetic cycle used for the synthesis of the 30 mer dTT(ATTT) 7 (Table 1 , cycle C). The effect of capping during oligomer synthesis was assessed by electrophoresis on a 20% PAG (Figure 4 , lane 1, without capping and lane 3, with capping). It is clear from the gel results that the crude sequence by cycle C was already pure, indicating the effectiveness of the new capping agent, 6. We have also compared the use of the improved new phosphite and phosphoramidite methods in terms of the deprotection of dTT(ATTT) 7 . Although there are not a significant difference between the two quantitatively ( Figure 4 , lane 2, phosphoramidite method; lane 3 improved new phosphite method), the improved new phosphite method was easier to prepare the phosphite units (3) and unnecessary of the protection at the phosphorus center.
Recently, oligonucleotides complementary to viral RNA have been shown to inhibit viral replication in cell cultures with Rous sarcoma virus [14, 15] , human immunodeficiency virus (HIV) [16, 17] , vesicular stomatitis virus [18] [19] [20] , herpes simplex virus [18, 21] , and influenza virus [22] . Experiments with normal (phosphodiester-bonds) antisense oligodeoxyribonucleotides as inhibitors have indicated that these comparatively short oligonucleotides can be taken up by cells in culture and may also be effective in producing modulation of gene expression. The relatively short half-lives of normal oligonucleotides in serum and in cells due to the presence of nucleases, and low permeability of these charged molecules into normal cells, limit their potential usefulness in vivo. To overcome these problems, some of antisense oligonucleotides have been modified on backbone as methylphosphonates, [18, 21] or phosphorothioates [17] .
To availability of the new phosphite approach can be demonstrated in the synthesis of antisense oligonucleotide analogues having phosphate and phosphorothioate bonds. The synthesis of antisense oligodeoxyribonucleotide, 5'-dCACCC-AATTCTGAAAATGGA-3', complementary sequence to the splice acceptor site in HTLV-HI [16, 17] was performed smoothly. The solid support was treated with cone, ammonia at 55°C for 6 h. The tritylated product was separated by reverse phase C-18 silica gel and unblocked with 80% AcOH. The unblocked oligomer was further purified by reverse phase C-18 HPLC. The main peak was found to be homogeneous by TSKgel DEAE 2SW and gel electrophoresis. It was hydrolyzed with snake venom phosphodiesterase and alkaline phosphatase and the four nucleosides were analyzed by reverse phase C-18 HPLC. For the phosphorothioate, the oxidation step was replaced by treatment with 5% sulfur in CS 2 /pyridine/triethylamine (45:45:10) for up to 2 h, depending on the chain length. After the usual deprotection, isolation of the desired oligomer, 5'-dCsAsCsCsCsAsAsTsTsCsTsGsAsAsAsAsTsGsGsA-3' was performed by TSKgel DEAE 2SW HPLC. The main peak was found to be homogeneous by reverse phase C-18 HPLC and by gel electrophoresis. In this case, a small amount of oligomer attached to CPG was taken before the final treatment with sulfur and oxidized with 0.1 MI 2 solution to phosphodiesters. The product was used for determination of the base composition by enzymatic degradation to nucleosides followed by HPLC.
These results and those shown above clearly demonstrate that the improved new phosphite unit method could prove to be very effective for the synthesis of medium size DNA fragments on a solid support. The phosphite unit (3) and capping agent (6) are readily activated by N-methylimidazloe under very mild conditions. It is noted that this operation involves a one-pot reaction, which is an advantage over both the phosphite and Hphosphonate approaches. Further, this method can be considered as an easy and efficient route a variety of internucleotide phosphate analogues of DNA containing the naturally occurring deoxynucleotides.
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